BRC-002 for Pain and Health in Complex Regional Pain Syndrome
This study is looking at how a high CBD (cannabidiol) cannabis extract called BRC-002 might help people with Complex Regional Pain Syndrome (CRPS), a chronic pain condition. Researchers want to understand if BRC-002 can reduce pain and improve overall health, and how it works in the body. They will compare BRC-002 to a placebo (an inactive substance) to see if it makes a difference. You might be able to join if you are between 21 and 75 years old, can speak English, have no major medical history, and haven't used cannabis or CBD in the last 30 days. The main goal is to see changes in CRPS pain and heat pain over 42 days.
- Study design
- This is an interventional study planning to enroll 52 participants. It will compare BRC-002 to a placebo.
- What's involved
- You would go through a screening period, a six-week treatment period, and a two-week follow-up. During this time, multiple tests will be done, including psychological and inflammatory marker testing.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for two weeks after the six-week treatment period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Fadel Zeidan, PhD · PRINCIPAL_INVESTIGATOR · UC San Diego
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in complex regional pain syndrome pain and heat pain measured with VASDay 1 - Day 42
Change from baseline in pain intensity and unpleasantness ratings using an 11-point Visual Analog Scale in response to heat and ongoing CRPS pain